Ncyte® Endothelial Cells are produced through a well-defined in vitro differentiation process from human induced pluripotent stem cells (iPSC) and express typical endothelial cell markers, such as CD31 and CD144.
These cells are the ideal tool to provide relevant predictions of your drug’s effect on endothelial cell function. They can be utilized over the entire drug discovery process, from the large screening campaigns for hit identification to critical decision-making in hit-2-lead or lead optimization.